Transcat (NASDAQ:TRNS) Lowered to “Hold” at Northland Capmk

Northland Capmk cut shares of Transcat (NASDAQ:TRNSFree Report) from a strong-buy rating to a hold rating in a research note released on Wednesday morning, Zacks.com reports. Northland Capmk also issued estimates for Transcat’s FY2029 earnings at $2.85 EPS.

Several other brokerages have also recently issued reports on TRNS. Northland Securities cut shares of Transcat from an outperform rating to a market perform rating in a report on Wednesday. HC Wainwright raised their target price on shares of Transcat from $124.00 to $156.00 and gave the stock a buy rating in a report on Wednesday. Oppenheimer raised their target price on shares of Transcat from $125.00 to $160.00 and gave the stock an outperform rating in a report on Wednesday. Finally, TheStreet raised shares of Transcat from a c+ rating to a b rating in a report on Wednesday, January 31st. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, Transcat presently has a consensus rating of Hold and an average price target of $134.50.

Read Our Latest Research Report on Transcat

Transcat Trading Up 0.2 %

NASDAQ TRNS opened at $142.18 on Wednesday. The company has a fifty day simple moving average of $113.21 and a two-hundred day simple moving average of $105.94. The stock has a market cap of $1.26 billion, a P/E ratio of 89.42 and a beta of 0.61. Transcat has a 12-month low of $81.26 and a 12-month high of $147.00. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 3,343 shares of the firm’s stock in a transaction on Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the sale, the chief executive officer now owns 103,692 shares in the company, valued at $12,870,251.04. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. In other news, CEO Lee D. Rudow sold 2,373 shares of Transcat stock in a transaction dated Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the sale, the chief executive officer now owns 103,688 shares in the company, valued at $11,553,953.84. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Lee D. Rudow sold 3,343 shares of Transcat stock in a transaction dated Monday, May 20th. The shares were sold at an average price of $124.12, for a total transaction of $414,933.16. Following the completion of the sale, the chief executive officer now owns 103,692 shares in the company, valued at approximately $12,870,251.04. The disclosure for this sale can be found here. 4.20% of the stock is owned by company insiders.

Institutional Trading of Transcat

Several institutional investors have recently modified their holdings of TRNS. State Board of Administration of Florida Retirement System acquired a new stake in shares of Transcat in the third quarter valued at about $207,000. Arizona State Retirement System acquired a new stake in shares of Transcat in the third quarter valued at about $213,000. Virtu Financial LLC acquired a new stake in shares of Transcat in the first quarter valued at about $224,000. Quantbot Technologies LP grew its position in shares of Transcat by 118.2% in the third quarter. Quantbot Technologies LP now owns 2,370 shares of the scientific and technical instruments company’s stock valued at $232,000 after purchasing an additional 1,284 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Transcat by 13.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,347 shares of the scientific and technical instruments company’s stock valued at $262,000 after purchasing an additional 284 shares during the period. Institutional investors and hedge funds own 98.34% of the company’s stock.

About Transcat

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

See Also

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.